Baymatob™ team at the NSW Medical Device Fund announcements from left, Saba Easwaramoorthy, Karin Birkner, Dr Sarah McDonald, Laura Mullins, Nicole Vu, and Dr Rishi Ramakrishnan (source: BaymatobTM)
BaymatobTM has been awarded $2.96M by the NSW Medical Devices Fund to conduct pre-trial development on OliTM. A total of four companies received funding for the 2019 round of the Medical Devices Fund with around $6.8M being awarded. BaymatobTM is a recipient of the NSW Medical Devices Fund, having received $1.47M in 2017 towards the development of OliTM. The NSW Medical Devices Fund began in 2013 and has awarded more than $50 million across 31 different technologies. This is a unique fund making it possible to progress the development and commercialisation of medical technologies within Australia.
Further information on the fund and recipients can be found here.
